TIMP1 and metabolic dysfunction-associated steatotic liver disease: In consideration of fatty liver groups, the results showed that the combination therapy group (NAFLD+LGG+ HIIT) caused a significant decrease in TIMP-1 mRNA compared to the NAFLD group (p < 0.001) (Figure 3(Fig. 3)).